Rosa Gini (Florence, IT)
Dr Gini is a data scientist focused on secondary use of electronic health records for pharmacoepidemiology and health services research. Her specific interest is accurate, reliable, transparent and fast generation of evidence to support health policy making. She has experience in data integration from diverse data sources and data validation. She is the Head of the Pharmacoepidemiology Unit of the Agenzia regionale di sanità della Toscana, a public health agency in Florence, Italy. This unit, comprising several units of personnel and contributors from the three Tuscan universities and from other Tuscan research centers, is involved in many observational studies on utilization, safety and effectiveness of drugs in Tuscany, in national or in multi-national networks of databases.
Regarding her main current projects, in Tuscany, she is responsible for conducting drug utilization, safety and comparative effectiveness studies of interest for decision making on drug policy. Currently, she is leading studies on drugs to treat non-small cell lung cancer, trajectories of use of biologic drugs for rheumatologic, dermatologic, and gastroenterologic indications, cholesterol-lowering drugs, antidotes for direct anticoagulant drugs, incretins for type 2 diabetes, antivascular endothelial growth factor agents for retinal diseases, and others. In Italy, she is involved in several multi-regional studies, especially focusing on drug utilization in pregnancy and on drug utilization of biosimilar drugs. In Europe, she is co-lead of the data science work package of ConcePTION, a project funded by IMI (Innovative Medicine Initiative) to build a pan-European ecosystem for generating, monitoring, and providing robust information on medication safety in pregnancy and breastfeeding. She is also involved in several EMA tenders and Post Authorisation Safety Studies in networks of European organizations.